Overview Financials News + Filings Key Docs Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Tango Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/22/2023 |
3
| Third Rock Ventures VI, L.P. (Director) has filed a Form 3 on Tango Therapeutics, Inc. |
| 08/15/2023 |
4
| Boxer Capital, LLC (See remarks) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Bought 475,000 shares
@ $5.15, valued at
$2.4M
Bought 2,340,579 options to buy
@ $5.1499, valued at
$12.1M
|
|
| 06/08/2023 |
4
| Rothenberg Mace (Director) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $3.55, valued at
$106.5k
|
|
| 06/08/2023 |
4
| Calhoun Lesley Ann (Director) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $3.55, valued at
$106.5k
|
|
| 06/08/2023 |
4
| Borisy Alexis (Director) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $3.55, valued at
$106.5k
|
|
| 06/08/2023 |
4
| Huber Reid M (Director) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $3.55, valued at
$106.5k
|
|
| 06/08/2023 |
4
| Peters Malte (Director) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $3.55, valued at
$106.5k
|
|
| 06/08/2023 |
4
| Davis Aaron I. (Director) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $3.55, valued at
$106.5k
|
|
| 03/02/2023 |
4
| Crystal Adam (See Remarks) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 81,250 shares
@ $0
Granted 487,500 options to buy
@ $5.2, valued at
$2.5M
|
|
| 03/02/2023 |
4
| Weber Barbara (CEO) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 89,545 shares
@ $0
Granted 537,273 options to buy
@ $5.2, valued at
$2.8M
|
|
| 03/02/2023 |
4
| Beckman Daniella (CFO) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 32,842 shares
@ $0
Granted 197,051 options to buy
@ $5.2, valued at
$1M
|
|
| 03/02/2023 |
4
| Barry Douglas (General Counsel) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 23,898 shares
@ $0
Granted 143,391 options to buy
@ $5.2, valued at
$745.6k
|
|
| 03/02/2023 |
3
| Crystal Adam (See Remarks) has filed a Form 3 on Tango Therapeutics, Inc. |
| 03/02/2023 |
4
| Huang Alan (Chief Scientific Officer) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 31,697 shares
@ $0
Granted 190,181 options to buy
@ $5.2, valued at
$988.9k
|
|
| 12/05/2022 |
4
| Weitzman Aaron (Chief Medical Officer) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $7.73, valued at
$2.7M
|
|
| 12/05/2022 |
3
| Weitzman Aaron (Chief Medical Officer) has filed a Form 3 on Tango Therapeutics, Inc. |
| 10/13/2022 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Bought 117,000 shares
@ $4.2539, valued at
$497.7k
Bought 50,000 shares
@ $4.4328, valued at
$221.6k
Bought 70,000 shares
@ $4.6461, valued at
$325.2k
|
|
| 10/06/2022 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Bought 25,606 shares
@ $3.6701, valued at
$94k
Bought 45,500 shares
@ $3.9262, valued at
$178.6k
Bought 40,500 shares
@ $3.8373, valued at
$155.4k
Bought 70,394 shares
@ $4.0638, valued at
$286.1k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Peters Malte (Director) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.9, valued at
$236k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Rothenberg Mace (Director) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.9, valued at
$236k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
3
| Braslyn Ltd. (10% Owner) has filed a Form 3 on Tango Therapeutics, Inc. |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/03/2021 |
4
| Rudoltz Marc (Chief Medical Officer) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $12.91, valued at
$4.5M
|
|
| 11/01/2021 |
3
| Rudoltz Marc (Chief Medical Officer) has filed a Form 3 on Tango Therapeutics, Inc. |
| 11/01/2021 |
3
| Barry Douglas (See Remarks) has filed a Form 3 on Tango Therapeutics, Inc. |
| 08/20/2021 |
3
| BCTG Holdings, LLC (10% Owner) has filed a Form 3 on Tango Therapeutics, Inc. |
| 08/20/2021 |
3
| Boxer Capital, LLC (10% Owner) has filed a Form 3 on Tango Therapeutics, Inc. |
|
|
|